Sea You at Fetch Long Beach
|Articles|February 25, 2008

LSU to host small animal symposium

Baton Rouge, La. - 2/25/08 - The Louisiana State University (LSU) School of Veterinary Medicine (SVM) will host its Small Animal Symposium in April that will focus on canine and feline infectious diseases.

Baton Rouge, La. - 2/25/08 - The Louisiana State University (LSU) School of Veterinary Medicine (SVM) will host its Small Animal Symposium in April that will focus on canine and feline infectious diseases.

Scheduled for April 27, the Pfizer Animal Health-sponsored meeting will feature speaker Dr. Edward Breitschwerdt, professor of internal medicine at the North Carolina State University College of Veterinary Medicine, who will discuss the molecular diagnosis of infectious diseases, persistent blood-borne infection, vector-borne infections and canine bartonellosis.

Canine ehrlichiosis, anaplasmosis, methicillin-resistant staphylococci, mycoses, canine leptospirosis, endocarditis, American trypanosomiasis and infectious disease cases will also be reviewed during the symposium, which will count as 8 hours of continuing education credit.

Featured LSU SVM speakers include Drs. Mark Acierno, assistant professor of companion animal medicine; Susan Eddlestone, assistant professor of veterinary medicine; Joseph Taboada, professor of veterinary medicine and associate dean for student and academic affairs; Amy Grooters, associate professor of companion animal medicine; and Keith Strickland, clinical associate professor of veterinary cardiology, among others.

Registrations received by April 23 are complimentary. An administrative fee of $25 will be charged for any registrations received after, or for those submitted on-site. To sign up, contact the LSU SVM at (225) 578-9900 or visit their web site .


Related to this article

Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.